At NPR, Nina Totenberg describes the decision as a “major victory for companies like Roche, Pfizer, Intel, and others that collaborate with universities on research with an eye toward marketing future discoveries”; Eric Kelderman of the Chronicle of Higher Education adds that the ruling is also a victory for faculty members, as well as a “warning to universities to carefully check the language and grammar of the contracts they sign with researchers. [read post]